INTRODUCTION
============

Intracellular redox state determines the direction of redox reactions that occur in the cell, and is determined by the balance of pro-oxidants compared with antioxidants. Oxidising conditions result from an increase in levels of pro-oxidant reactive oxygen (or nitrogen) species (ROS, or RNS) or a decrease in reducing power. Although high levels of ROS (a state known as oxidative stress) are detrimental to the cellular environment, low levels of ROS are required for normal signalling in healthy cells ([@b127-molce-39-1-6]).

One of the first examples of functional signalling initiated by ROS (aka redox signalling) was recognised in the mid-1970s, when it was observed that high levels of oxidising reagents induce an insulin-like response ([@b25-molce-39-1-6]). Indications that ROS can also induce a direct transcriptional response came from studies on bacterial OxyR ([@b131-molce-39-1-6]) and mammalian AP-1 (c-Fos and c-Jun) ([@b1-molce-39-1-6]) transcription factors, which showed that oxidation of these proteins modulates their transcriptional activities. By the mid-1990s, Sundaresan and colleagues had noted that activation of the platelet derived growth factor (PDGF) signalling pathway induces an increase in intracellular hydrogen peroxide (H~2~O~2~) concentration that is required for functional PDGF signalling. Based on these findings, they proposed that H~2~O~2~ potentially functioned as a second messenger in this pathway ([@b133-molce-39-1-6]), a hypothesis that was subsequently confirmed and then expanded to include other signalling pathways (as exemplified below).

In contrast to other second messengers (like calcium or cAMP), H~2~O~2~ is not recognised by specialised binding (or effector) proteins. Instead, signalling through H~2~O~2~ proceeds via the oxidation of reactive cysteine residues. The response to a H~2~O~2~ transient is not binary however, and can lead to different molecular effects, depending on the concentration of H~2~O~2~, the identity of the oxidised cysteine, the degree of oxidation, and the nature of the oxidised cysteine's subsequent reactions. Essential to this H~2~O~2~-mediated signal transduction therefore, is the principle of differential sensitivity of intracellular cysteines to oxidation. This is readily understood in the case of buried vs. surface-exposed cysteine residues but, as discussed below, also includes differential redox sensitivity of surface cysteines within the same protein.

FORMATION AND DECOMPOSITION OF REACTIVE OXYGEN SPECIES
======================================================

Reactive oxygen species (ROS) is a generic term for many different oxygen-derivatives, including the extremely reactive hydroxyl radical (^·^OH), highly reactive superoxide anion (O~2~^·−^) and the less reactive but more abundant and diffusible H~2~O~2~; these latter features eminently suit H~2~O~2~ for its signalling role. As a result of aerobic metabolism, superoxide anions are constantly formed as natural by-products of mitochondrial respiration; indeed it has been estimated that about 1--2% of all acceptor oxygen escapes full reduction to water and exits the mitochondria as O~2~^·−^ ([@b3-molce-39-1-6]). Moreover, O~2~^.−^ is actively produced by NADPH oxidases (NOXs) and xanthine oxidases (XO) ([@b29-molce-39-1-6]) in response to growth factor signalling e.g. insulin and PDGF pathways.

Due to its high reactivity, an increase in O~2~^.−^ levels induces damage to essential cellular components such as DNA, fatty acids and proteins. To protect themselves against ROS-induced damage, cells express antioxidant systems that decompose ROS. Mitochondrial manganese superoxide dismutase (MnSOD) and cytoplasmic copper/zinc superoxide dismutase (CuZnSOD) catalyse the dismutation of O~2~^·−^ to less reactive H~2~O~2~ ([@b80-molce-39-1-6]). Proteins that control cytoplasmic H~2~O~2~ levels are peroxiredoxin 1 and 2 (PRX1 and 2) and glutathione peroxidase (GPX) ([@b45-molce-39-1-6]). Followed protein oxidation, PRX and GPX are recycled via reduction by the thioredoxin (TXN) and glutaredoxin (GRX) systems, respectively. Both TXN and GRX are ultimately supplied with reducing equivalents in the form of NADPH -- the cytosol's master redox currency (see below).

CYSTEINE-DEPENDENT REDOX SIGNALLING
===================================

As noted above, redox signalling proceeds through the oxidation of specific cysteine residues in a wide variety of proteins. The sulphur atom in cysteine is sensitive to several degrees of oxidation by H~2~O~2~ ([Fig. 1A](#f1-molce-39-1-6){ref-type="fig"}). In its reduced state, it exists as a thiol (−SH) or as a deprotonated thiolate anion (−S^−^). The thiolate anion is most susceptible to oxidation, and upon successive encounters with H~2~O~2~, it reacts to form first a sulphenic acid (−SOH), then a sulphinic acid (−SO~2~H), then a fully oxidised sulphonic acid (−SO~3~H). Of these, a sulphinic acid can be actively reduced by sulphiredoxin1 (SRX) to form a sulphenic acid ([@b19-molce-39-1-6]; [@b146-molce-39-1-6]). Both sulphinic and sulphonic forms of cysteine may be referred to as "over-" or "hyperoxidised", but only the sulphonic form is irreversibly oxidised,

The initial protonation state of a cysteine residue is determined by its pKa. The pKa of free cysteine is 8.3--8.5, meaning that at cytosolic pH (∼7.4) free cysteines are fully protonated. Similarly, GSH has a pKa of 8.8 ([@b144-molce-39-1-6]) and is fully protonated under physiological circumstances. Instead, redox sensitive proteins have a much lower pKa: the catalytic cysteine of TXN has a pKa of 6.5 ([@b41-molce-39-1-6]), the pKa of the catalytic cysteine in PTP1B is even lower at 5.4 ([@b84-molce-39-1-6]), and PRX catalytic cysteines have a pKa between 5--6 ([@b104-molce-39-1-6]). Low pKa, however, is not sufficient to explain the higher reactivity of some cysteines compared with others. For example, although both PRX2 and PTP1B catalytic cysteines are fully deprotonated at physiological pH, the reaction rate of PRX2 with H~2~O~2~ is approximately six orders of magnitude higher than PTP1B. It is thought therefore, that residues surrounding highly redox-sensitive cysteines are critical for determining their activity, not only by facilitating an electrostatic microenvironment which favours deprotonation but also stabilising the transition state required for their high reactivity ([@b10-molce-39-1-6]). For example, PRX2 and 3 contain a highly conserved arginine residue that is critical to their peroxidase function ([@b88-molce-39-1-6]).

Sulphenic acids are believed to be short-lived oxidation intermediates as they favour reaction with other cysteinethiols to form intra- or intermolecular disulphides (-S-S-) ([Fig. 1A](#f1-molce-39-1-6){ref-type="fig"}) ([@b115-molce-39-1-6]). Intramolecular disulphides potentially mediate conformational changes that facilitate cellular signal transduction. For example, formation of an intramolecular disulphide in Kelch-like ECH-associated protein 1 (KEAP1) inhibits its binding to the transcription factor NRF2 (Nuclear factor (erythroid-derived)-like 2). As KEAP1 facilitates NRF2 ubiquitination and degradation, oxidising conditions lead to activation of NRF2 and its transcriptional program. Being an important regulator of the cellular antioxidant response (with targets such as SOD, PRX and SRX) this allows for a proper cellular response to oxidative insults ([@b48-molce-39-1-6]).

Intermolecular disulphides lead to covalently linked (homo- or hetero) dimers or multimers. Such a covalent interaction potentially stabilises otherwise transient interactions, thereby allowing changes in protein-protein interaction-mediated signalling ([@b24-molce-39-1-6]; [@b109-molce-39-1-6]). Several observations indicate that such intermolecular disulphides can directly regulate cytosolic enzyme activity. For example, the activities of protein kinase A (PKA) ([@b16-molce-39-1-6]), protein kinase G (PKG) ([@b15-molce-39-1-6]; [@b107-molce-39-1-6]) and apoptosis signal-regulating kinase 1 (ASK1) ([@b87-molce-39-1-6]) are under disulphide-mediated redox control. Several transcription factors have also been shown to be regulated by disulphide-mediated interactions, with well-known examples being the Forkhead Box O tumour suppressor proteins, FOXO3 and FOXO4, both of which having been implicated in a plethora of disulphide-dependent complexes ([@b26-molce-39-1-6]; [@b108-molce-39-1-6]; [@b110-molce-39-1-6]). ROS-induced nuclear accumulation and activation of both proteins is regulated in a (distinct) disulphide-dependent manner.

Alternatively, sulphenic acids can form intermolecular disulphides with the highly abundant tripeptide glutathione (Glu-Cys-Gly) (GSH), known as glutathionylation. Glutathionylation is considered an important posttranslational modification that serves several functions. First of all, it protects the sulphur from hyperoxidation, thereby increasing protein stability. Moreover, glutathionylation affects protein activity by altering cysteine function (see below) or may form new docking sites for protein-protein interactions ([@b43-molce-39-1-6]).

Due to the nucleophilic character of the thiolate anion, cysteines often play important roles in protein activity or structure. Therefore, besides mediating disulphide-dependent signalling, oxidation of functional cysteines can greatly affect cellular signalling. Many enzymes feature catalytic cysteines in their active sites, with oxidation leading to enzymatic inhibition. Under physiological conditions, sulphenic acid formation has been shown to inhibit the activities of enzymes as diverse as phospho-tyrosine phosphatases \[e.g. protein tyrosine phosphatase 1B (PTP1B) ([@b67-molce-39-1-6])\], deubiquitinating enzymes \[e.g. ubiquitin specific peptidase 1 (USP1), USP7 and A20 ([@b23-molce-39-1-6]; [@b64-molce-39-1-6])\] and the glycolytic enzyme GAPDH ([@b103-molce-39-1-6]). In addition to catalytic cysteine oxidation, cysteines are often found at sites of structural significance, and oxidation has therefore been suggested to induce functional changes in protein structure. For example, cysteines in zinc finger motifs are crucial to secondary structure and DNA binding. Oxidation of zinc finger cysteines leads to Zn^2+^ release and subsequent conformational change/loss of DNA binding, and increased free Zn^2+^ itself can elicit further signalling responses. This redox control by Zn^2+^ exclusion has been demonstrated for the zinc finger transcription factors p53 ([@b113-molce-39-1-6]) and SP-1 ([@b141-molce-39-1-6]; [@b149-molce-39-1-6]), for example.

Excepting --SO~3~, all cysteine derivatives described above are reversible. Inter- or intramolecular disulphides become reduced through the TXN and GRX systems ([@b45-molce-39-1-6]). Recycling of TXN is catalysed by thioredoxin reductase (TXNR) ([Fig. 1B](#f1-molce-39-1-6){ref-type="fig"}), whereas GRX recycles by oxidation transfer to a free GSH molecule. Oxidised GSH (GSSG) in turn is recycled by glutathione reductase (GR), with both oxidised TXNR and GR being ultimately reduced at the expense of NADPH. The intra-cellular GSH pool and NADP/NADPH ratio are thus critical determinants of cellular reduction potential.

SPECIFICITY OF CYSTEINE-DEPENDENT REDOX SIGNALLING
==================================================

Cells possess extensive antioxidant systems to maintain intra-cellular ROS within a physiological range. GPX, PRX1 and 2 are highly abundant proteins, and their reaction rates with H~2~O~2~ are 4--6 orders of magnitude above that of most redox sensitive cysteines. For example, the rate constant of PRX2 for its reaction with H~2~O~2~ is ∼4^\*^10^7^ M^−1^s^−1^, whereas that of PTP1B is 20 M^−1^s^−1^. As the protein levels of PRX1 and 2 are high \[20 μM versus e.g. 0.1 μM for PTP1B ([@b145-molce-39-1-6])\], and their reaction rate with H~2~O~2~ is much higher than most protein thiols, it seems unlikely that PTP1B (or another similarly reactive protein thiol) would become oxidised upon physiological increases in H~2~O~2~ (i.e. those that mediate signalling, without inducing damage) ([Fig. 2A](#f2-molce-39-1-6){ref-type="fig"}). Oxidation and inhibition of PTP1B does occur however ([@b67-molce-39-1-6]), as do the other protein oxidations described above. Although the sequence of molecular events during each oxidation are incompletely understood, in general the mechanism allowing cells to detect and respond to H~2~O~2~-induced cysteine oxidation is understood by (a combination of) two models.

In the first model, localised inactivation of PRX1/2 allows other proteins to become oxidised ([Fig. 2B](#f2-molce-39-1-6){ref-type="fig"}). The activity of PRX proteins is regulated by either oxidative or non-oxidative modifications. In the first case, localised increase in H~2~O~2~ levels (e.g. through NOX activation) overwhelms the "flood-gate" of the local antioxidant capacity leading to hyperoxidation of PRX peroxidatic cysteines, preventing their recycling. A localised pool of inactivated H~2~O~2~-scavenging enzymes results, allowing oxidation of less reactive thiol proteins ([@b146-molce-39-1-6]). Upon cessation of H~2~O~2~ production, the sulphinic acids are (slowly) recycled *via* SRX ([@b19-molce-39-1-6]), restoring normal redox balance. Besides oxidation-mediated regulation, tyrosine kinase-mediated phosphorylation of PRX1-tyr194 (e.g. by SRC) inactivates PRX1, contributing to localised inactivation of H~2~O~2~ scavenging enzymes. Interestingly, PRX2 is insensitive to such phosphorylation-dependent regulation. Instead, PRX2 is much more sensitive than PRX1 to hyperoxidation ([@b147-molce-39-1-6]). Taken together, oxidation-dependent and -independent mechanisms lead to inactivation of PRX proteins, allowing H~2~O~2~ to oxidise other proteins and activate redox signalling.

The second model also uses PRX oxidation as a starting point. In this case, cysteines are not oxidised directly by H~2~O~2~, but through PRX-mediated oxidation relay processes ([Fig. 2C](#f2-molce-39-1-6){ref-type="fig"}). Instead of forming a homodimer with another PRX protein, oxidised PRX can transfer its oxidation state to specific target proteins, thereby inducing disulphide formation on its binding partner resulting in PRX reduction ([@b55-molce-39-1-6]; [@b130-molce-39-1-6]). This is functionally equivalent to the oxidative protein folding catalysed by ER-resident oxidoreductin1 and protein disulphide isomerase, which facilitate non-native structural disulphide formation in the secretory pathway ([@b13-molce-39-1-6]). First identified in yeast ([@b28-molce-39-1-6]; [@b37-molce-39-1-6]), such protein-mediated redox relays participate in several mammalian signalling pathways. For example, GPX4 transfers its H~2~O~2~-mediated oxidation to keratin-like proteins to stimulate disulphide bond formation in developing sperm ([@b75-molce-39-1-6]). The first PRX-mediated redox relay was identified in the activation of ASK1. Here PRX1 plays an active and specific disulphide transfer role by facilitating ASK1 dimerisation, such that covalent, but transient, PRX1-ASK1 complexes (but not PRX2-ASK1) were observed upon an increase in ROS ([@b55-molce-39-1-6]). Interestingly, besides explaining the occurrence of oxidation in the cytosol, the redox-relay model might also explain how specific redox signalling can occur through (scaffold-regulated) specific interactions between PRX1 and its target proteins.

CIRCADIAN TIMEKEEPING MECHANISMS DICTATE HOMEOSTASIS
====================================================

The term "homeostasis" \[homoios (similar) and stasis (standing still)\] implies the existence of a biological steady state that is "preferred" and returned to, following a departure; however physiology is not as constant as suggested in some textbooks. Circadian (meaning "about daily") timekeeping mechanisms allow organisms to adapt to the 24-hour daily cycle, allowing them to anticipate, and resonate with, the predictable environmental cycle of day and night ([@b30-molce-39-1-6]). The mammalian "master clock", resides in the hypothalamic suprachiasmatic nucleus (SCN), where it co-ordinates systemic adaptions to the day-night cycle; timing the temporal orchestration of overt physiology and behaviours, such as sleep/wake ([@b143-molce-39-1-6]). It is now well established however, that essentially every cell in the body is possessed with innate circadian timekeeping capacity ([@b142-molce-39-1-6]; [@b152-molce-39-1-6]). *In vivo*, these cell-autonomous oscillations are normally synchronised by the timing of endocrine signals, such as glucorticoids, and by other cues such as body temperature rhythms ([@b83-molce-39-1-6]; [@b125-molce-39-1-6]), but critically cellular circadian rhythms are not dependent upon any extracellular timing signals. Indeed using a bioluminescent reporter (PER2::LUC), under constant conditions, circadian gene expression rhythms in primary mouse fibroblasts were recently shown to persist for longer than a month *ex vivo* ([@b71-molce-39-1-6]).

Circadian rhythms permeate mammalian cell biology, with 'omics studies in tissues and isolated cells both revealing that significant proportions of gene expression and metabolism are circadian regulated ([@b4-molce-39-1-6]; [@b7-molce-39-1-6]), with a commensurate impact upon biological function. For example, a recent report by ([@b157-molce-39-1-6]) found that more than a third of protein-coding genes in the mouse genome exhibit circadian regulation in one or more tissues. In consequence, it should not be surprising that from cell division ([@b9-molce-39-1-6]; [@b35-molce-39-1-6]; [@b77-molce-39-1-6]) to signal transduction ([@b94-molce-39-1-6]), from inflammation ([@b39-molce-39-1-6]) to neuronal long-term potentiation ([@b20-molce-39-1-6]), circadian rhythms modulate cellular activity to support anticipated demand. A good example is the upregulation of transcripts and activities associated with gluconeogenesis and glycogenolysis at the beginning of the rest/inactive phase in mouse liver, which maintain blood glucose levels during the daily fast that occurs during sleep ([@b156-molce-39-1-6]).

The growing number of reports, discussed below, showing that cellular redox balance is circadian regulated should not come as any shock. Based on the evidence that redox signalling mediates many cellular functions, including the activity of specific transcription factors and metabolic enzymes, it is plausible the converse may also be true: that redox signalling regulates circadian timekeeping. A circadian output that also functions as a circadian input becomes indistinguishable from a core clock mechanism \[or zeitnehmer ([@b120-molce-39-1-6])\]. If cellular redox rhythms do constitute an important part of the circadian clock mechanism, then conceptual advances in both the redox and circadian field could readily be anticipated. In the rest of this review therefore, we wish to appraise the evidence supporting the hypothesis that cellular circadian rhythms reciprocally regulate cellular redox balance. To do so it is necessary to introduce some key paradigms and concepts from circadian research.

INPUTS, OUTPUTS AND MOLECULAR RHYTHMS -- SEVERAL COGS IN ONE CLOCK
==================================================================

In eukaryotes the cell is the simplest level of biological scale that we know to possess circadian timekeeping. Cell biological approaches are therefore of utility for mechanistic investigations. The circadian vocabulary has largely developed from concepts based on behavioural and physiological measurements, but can be extended to define timekeeping at the cellular scale. At the organismal level the essential criteria defining a circadian rhythm are that it: persists with an approximately twenty-four hour period under constant conditions; is entrained by relevant external timing cues (zeitgebers, e.g. light, feeding); and is temperature-compensated ([@b105-molce-39-1-6]). Refining this, we employ the term "cellular clock" to describe the complete set of cellular mechanisms and components that are necessary and sufficient to maintain a temperature-compensated ∼24 h oscillation in some biological process, that is sensitive to appropriate extracellular stimuli.

Whilst the functional contribution of assorted "clock genes" towards coordinating circadian physiology at the organismal level is proven beyond reasonable doubt ([@b8-molce-39-1-6]), the mammalian cellular clock mechanism is not completely understood at this time. By this we mean that, to our knowledge, no extant hypothesis adequately explains in biochemical detail a causal chain of defined molecular events that give rise to a self-sustained oscillation of circadian period ([@b96-molce-39-1-6]). Great progress has been made, however, in characterising many input signals to, and rhythmic outputs from, the cellular clock. Moreover many of its essential and auxiliary, transcriptional and post-translational components have been identified. The foremost of these are described below.

In the vast majority of contexts and mammalian cell types, several inter-connected delayed Gene Expression Feedback Loops (GEFLs; also known as Transcription-Translation Feedback Loops, TTFLs) regulate circadian gene expression. By binding to promoter regions in diverse clock-controlled genes, and acting in concert with tissue-specific promoters, cycling clock gene activity readily accounts for the majority of gene expression rhythms observed *in vivo* ([@b83-molce-39-1-6]; [@b137-molce-39-1-6]; [@b157-molce-39-1-6]). The term "clock gene" itself is rather poorly defined, but in the broadest sense could be taken to mean a gene whose expression contributes to the fidelity of circadian timekeeping, and whose gene product directly or indirectly represses its own activity following a lengthy delay, leading to an oscillation in gene expression. As such a gene expression delayed negative feedback loop has been proposed as the essential mechanistic basis of the circadian rhythm in animals ([@b46-molce-39-1-6]; [@b121-molce-39-1-6]) as well as plants and fungi ([@b30-molce-39-1-6]); although it should be mentioned that the particular clock protein transcription factors identified in each eukaryotic kingdom share no similarity.

In short, the main mammalian GEFL ([Fig. 3](#f3-molce-39-1-6){ref-type="fig"}) begins with the activating bHLH-PAS (basic Helix-Loop-Helix-PER-ARNT-SIM) transcription factors BMAL1 (brain and muscle ARNT-like protein) and CLOCK (circadian locomotor output cycle kaput) or homologue NPAS2 (neuronal PAS-domain containing protein 2). Their activity at E-box promoters results in upregulation of many targets, amongst which are the period (encoding PER1, 2 and 3) and cryptochrome genes (encoding CRY1 and CRY2). PER and CRY proteins gradually accumulate and together form a repressive complex, which eventually is licensed for inhibition of nuclear BMAL1 and CLOCK activity - thereby repressing their own transcription. Due to the time required to assemble sufficient levels of this repressive complex (the negative feedback is delayed), accompanied by extensive daily changes in surrounding chromatin structure and histone modification, an oscillation of PER and CRY proteins (and of other CLOCK-BMAL1) target genes, results ([@b30-molce-39-1-6]; [@b117-molce-39-1-6]).

In a secondary loop, the levels of BMAL1 (and other ROR-regulated genes) are regulated in a circadian fashion. Here, ROR (Retinoic acid-related Orphan Receptor) proteins induce the expression of genes bearing promoter ROR-elements (RORE), including BMAL1. BMAL1 in turn regulates the (rhythmic) expression of REV-ERB proteins, which repress ROR-mediated gene expression by competing for RORE binding, forming another delayed negative feedback.

Important to note, and a repetitive theme in circadian biology, most of the "clock genes" (PER, CRY, BMAL, REV-ERB) may be considered both as inputs and outputs of the cellular clock: they contribute to the organisation of the clock, but also oscillate themselves as a result. Due to the overt oscillations of these proteins and their transcripts, clock gene expression is commonly used as a reporter of the molecular clockwork. In particular, the Bmal1 promoter, the Per2 promoter and the PER2 coding sequence, all coupled with firefly luciferase, are frequently used to measure the period, amplitude and phase of circadian rhythms in cultured cells/tissues and even in freely behaving animals ([@b124-molce-39-1-6]; [@b126-molce-39-1-6]; [@b152-molce-39-1-6]).

Both of these feedback loops rely on a positive input and a delayed feedback for their persistent oscillatory activity. Compared with the length of a day, transcription and translation of clock genes occurs quickly (0.25 -- 1 h following activation), thus in the absence of extensive post-translational regulation, it is difficult to account for the delay constants that generate the slow kinetics of clock gene expression. Indeed, combined microarray and proteomic studies in mouse liver, show PER and CRY protein expression to peak roughly 6 hours later than peak mRNA expression of the same gene ([@b68-molce-39-1-6]). As might be expected, this delay is predominantly regulated post-translationally, as overlap of the mRNA peak and ribosomal mRNA loading ([@b6-molce-39-1-6]; [@b54-molce-39-1-6]) suggests that translation of the mRNA occurs without any delay. Turnover of the PER and CRY proteins, for example, is tightly regulated by post-translational modifications. In particular CK1δ/ε (casein kinase 1 δ and ε) phosphorylates PER2 and target it for β-TRCP-mediated ubiquitination ([@b32-molce-39-1-6]; [@b116-molce-39-1-6]), resulting in proteosomal degradation. Similarly, CRY is targeted for degradation by FBXL3-mediated ubiquitination ([@b40-molce-39-1-6]), which is counteracted by USP7 (HAUSP) ([@b99-molce-39-1-6]). Interestingly, the PER-CRY binding interface blocks the binding site for FBXL3, and PER binding to CRY thus protects it from degradation ([@b91-molce-39-1-6]). In addition to CK1δ/ε, other ubiquitous kinases such as glycogen synthase kinase 3β and casein kinase 2 contribute to regulating the stability, activity and subcellular localisation of clock proteins ([@b74-molce-39-1-6]; [@b96-molce-39-1-6]) which are additionally regulated by a further host of post-translational modifications including acetylation, N-glycosylation and sumoylation ([@b5-molce-39-1-6]; [@b17-molce-39-1-6]; [@b36-molce-39-1-6]; [@b56-molce-39-1-6]; [@b118-molce-39-1-6]).

CELLULAR CLOCKS DO NOT REQUIRE (CYCLING) TRANSCRIPTION
======================================================

Homozygous deletion of many of the core clock genes results in robust behavioural and cellular circadian phenotypes. These can be classified into three groups: (1) mild phenotype e.g. CLOCK ([@b27-molce-39-1-6]); (2) short or long period e.g. CRY1 and CRY2 knockout, respectively ([@b50-molce-39-1-6]); (3) no circadian rhythm detected (sometimes described as arrhythmic). In the last group, mice that lack either BMAL, or both CRY proteins, do not exhibit circadian rhythms in behaviour or clock gene transcription ([@b14-molce-39-1-6]; [@b50-molce-39-1-6]). These and other transgenic mouse models strongly suggest that the activity of clock proteins is necessary for the expression of normal circadian rhythms. Knockout mice do not demonstrate that clock gene expression is required to cycle *per se* though. Indeed when clock proteins are constitutively expressed the circadian phenotype is generally mild ([@b34-molce-39-1-6]; [@b38-molce-39-1-6]; [@b97-molce-39-1-6]), although overexpression can show more marked effects ([@b21-molce-39-1-6]). It is therefore plausible that a certain level of clock protein abundance is simply permissive for normally functioning circadian rhythms, and that their oscillations in abundance play an auxiliary (rather than essential) role in terms of cellular clock mechanism, but do serve to increase the amplitude, robustness and fidelity of the oscillation ([@b47-molce-39-1-6]).

In support of this possibility, several observations have suggested that clock gene transcriptional cycles may not be absolutely required for circadian rhythms at the cellular level ([@b96-molce-39-1-6]). For example, [@b100-molce-39-1-6] observed circadian rhythms in glucose metabolism in mouse embryonic stem cells, which lack rhythms in clock gene expression. Similarly, separate groups have observed circadian rhythms in global, and clock protein, translation in isolated human cells, and mouse SCN *ex vivo*, respectively, that were homozygous null for the "essential" clock gene bmal1 ([@b60-molce-39-1-6]; [@b72-molce-39-1-6]). Also PER2::LUC oscillations were found to persist in around 50% of SCN slices from mice that lack both CRY proteins, the "essential" repressors of the main GEFL ([@b79-molce-39-1-6]; [@b98-molce-39-1-6]). Moreover, inspired by prior experiments performed upon algal and cyanobacterial clocks ([@b90-molce-39-1-6]; [@b92-molce-39-1-6]; [@b134-molce-39-1-6]; [@b136-molce-39-1-6]), several groups have now observed circadian rhythms in isolated human and mouse red blood cells. Mammalian erythrocytes lack a nucleus, or any other organelles, and therefore lack the capacity for nascent gene expression. Thus the erythrocyte cellular clockwork cannot conceivably rely upon GEFLs. The main marker for erythrocyte rhythms employed in these studies was PRX hyperoxidation ([@b22-molce-39-1-6]; [@b49-molce-39-1-6]; [@b92-molce-39-1-6]), which showed a temperature-compensated circadian oscillation that could be entrained by externally applied temperature cycles (mimicking body temperature rhythms). As might be anticipated, the PRX-SO~2/3~ rhythm was accompanied by a rhythm in total NA(P)DH levels ([@b92-molce-39-1-6]), and was dependent upon SOD1 activity, haemoglobin auto-oxidation and proteasomal degradation ([@b22-molce-39-1-6]; [@b49-molce-39-1-6]).

In our opinion though, whilst the evidence that the cellular clock does not absolutely require transcription, cycling or otherwise, has become quite compelling, it is also true that gene expression cycles facilitated by rhythmic clock protein activity play an essential cellular timekeeping role under almost all normal circumstances. Therefore in considering how the cellular clock interacts with redox signalling, we find it unhelpful to arbitrarily apportion timekeeping function between transcriptional and non-transcriptional mechanisms, since both are cogs of the same cellular clockwork and it is unlikely that either alone would sustain a circadian rhythm with any robustness.

CIRCADIAN CONTROL OF THE CELLULAR REDOX STATE
=============================================

There is a substantial body of evidence demonstrating that the circadian clock regulates cellular redox state. First indications for this came from studies in the fungus *Neurospora crassa*, where it was shown that the oxidation state of nicotinamide adenine dinucleotide (the NAD/NADH ratio) exhibits daily rhythms ([@b11-molce-39-1-6]). Subsequent studies in other model systems have also found the redox balance of pyridine nucleotides to be circadian-regulated. For example, nicotinamide adenine dinucleotide phosphate oxidation (NADP/NADPH) oscillations have been observed in plants ([@b158-molce-39-1-6]); protein glutathionylation and flavin adenine nucleotide (FAD)/NADPH oscillate in rodent SCN *ex vivo* ([@b140-molce-39-1-6]); NAD/NADH oscillates in the epidermis of living mice ([@b132-molce-39-1-6]); total NAD(P)H oscillates in human erythrocytes ([@b92-molce-39-1-6]); as do total NAD levels in mouse liver and cultured myoblasts ([@b101-molce-39-1-6]). Besides rhythmic abundance of dinucleotides, recently the oxidation state of PRX proteins have been a useful marker for circadian redox oscillations. In addition to isolated erythrocytes and the alga *Ostreococcus tauri*, cell-autonomous circadian oscillations in PRX-SO~2/3~ levels have now been observed in a variety of organisms, cell lines and tissues ([@b31-molce-39-1-6]; [@b59-molce-39-1-6]; [@b92-molce-39-1-6]; [@b92-molce-39-1-6]). The oscillation in PRX-SO~2/3~ abundance appears to be a cellular clock output only, since PRX activity is not required for cellular circadian rhythms ([@b18-molce-39-1-6]). Rather it seems likely to be driven by an underlying rhythm in oxidative metabolism ([@b18-molce-39-1-6]; [@b52-molce-39-1-6]).

In line with the cellular clock being an important regulator of redox homeostasis, clock mutant mouse models exhibit ROS-associated phenotypes. Most pronounced is the premature ageing phenotype and shortened lifespan of BMAL1^−/−^ mice, which was partially rescued by life-long administration of the GSH-precursor N-acetyl cysteine (NAC) ([@b61-molce-39-1-6], [@b62-molce-39-1-6]). Fibroblasts and other tissues isolated from BMAL1^−/−^ mice exhibit very high ROS loads ([@b69-molce-39-1-6]; [@b86-molce-39-1-6]), presumably due to another role of BMAL1 as a transcriptional regulator of cellular antioxidant expression *via* NRF2 ([@b69-molce-39-1-6]; [@b102-molce-39-1-6]). Conversely, CRY1^−/−^/CRY2^−/−^ cells seem to suffer from reductive stress ([@b53-molce-39-1-6]; [@b101-molce-39-1-6]).

Logically, oscillations in cellular redox state could either result from rhythmic ROS production, or from the rhythmic recycling or rhythmic expression of cellular antioxidant proteins. In fact, all three of these appear to be circadian regulated, as will be exemplified below.

First, cellular metabolism is under circadian control ([@b7-molce-39-1-6]). As mitochondrial metabolism is the major source of cellular ROS in most cell types, rhythmic oxidative phosphorylation potentially contributes to cellular redox oscillations (excepting erythrocytes). As long ago as 1972 it was known that oxygen consumption of rat liver cells exhibit circadian oscillations ([@b66-molce-39-1-6]), suggesting some underlying circadian regulation of metabolic activity. Indeed, circadian oscillations in mitochondrial respiration have been found in mouse liver ([@b53-molce-39-1-6]; [@b101-molce-39-1-6]), skin ([@b132-molce-39-1-6]), and a myotube model ([@b101-molce-39-1-6]). These oscillations coincide with diurnal BMAL1-dependent oscillations in mitochondrial biogenesis, protein expression and morphology. Liver cells from liver-conditional BMAL1^−/−^ mice show diminished and arrhythmic respiration, swollen mitochondria and an increased ROS load, whereas these phenotypes are partially restored by expression of the fission protein FIS1, suggesting another role for BMAL1 in the regulation of mitochondrial quality control ([@b53-molce-39-1-6]). An additional explanation for this phenotype is found in the circadian regulation of NAD biosynthesis. As well as being an important electron carrier required in glycolysis and the Krebs cycle, NAD functions as a co-factor for several enzymes, among which are the Sirtuin histone (and protein) deacetylase (HDAC) proteins ([@b138-molce-39-1-6]). The rate of NAD production is regulated, in part, by the abundance and activity of nicotinamide phosphoribosyltransferase (NAMPT), which is under transcriptional control the BMAL1:CLOCK complex ([@b89-molce-39-1-6]; [@b114-molce-39-1-6]). The circadian expression of NAMPT is thought to result in circadian abundance of NAD, coinciding with the rhythmic activity of mitochondrial SIRT3 and deacetylation of several SIRT3 targets involved in mitochondrial metabolism ([@b101-molce-39-1-6]). In addition, nuclear SIRT6 is reported to be affected by NAD oscillations, remodelling chromatin structure to allow BMAL1:CLOCK DNA binding (thereby governing a positive feedback), and recruiting SREBP-1 to regulate the rhythmic expression of proteins involved in fatty acid and cholesterol metabolism ([@b76-molce-39-1-6]). BMAL1-deficient fibroblasts exhibit reduced NAD levels, reduced oxidative phosphorylation/fatty acid oxidation rates and increased glycolytic rate, which is rescued by pharmacological restoration of NAD levels ([@b101-molce-39-1-6]). Thus, via several different pathways, the BMAL1:CLOCK complex regulates mitochondrial metabolism and as such, mitochondrial ROS production.

Besides mitochondrial metabolism, NADPH oxidase (NOX) enzymes are implicated in the production of ROS. Clear circadian expression of NOX4 occurs in mouse lung, liver and kidney, for example, peaking in the opposite circadian phase to BMAL1 (CircaDB) ([@b106-molce-39-1-6]). In agreement with this, NOX4 expression is significantly increased in arteries isolated from BMAL1^−/−^ mice, as is the ROS load ([@b2-molce-39-1-6]). We are not aware of studies directly testing the role of NOX proteins in cellular redox oscillations, but as the phase relationship of NOX4 with BMAL1 is similar to that of the NAD and oxidative phosphorylation peak ([@b101-molce-39-1-6]), it seems plausible that NOX4 in some tissues contributes to circadian rhythms in ROS production.

Second, in addition to ROS production, cellular antioxidant capacity is also circadian regulated. For example, the NAMPT-mediated NAD oscillations described above allow for rhythmic activation of the nuclear HDAC function as well as rhythmic regulation of PER2 deacetylation and BMAL1:CLOCK activity (implicating NAD as both in- and outputs of cellular timekeeping) ([@b5-molce-39-1-6]; [@b89-molce-39-1-6]; [@b114-molce-39-1-6]). SIRT1 in particular is also implicated in the regulation of several non-clock transcription factors. Among these, p53 ([@b139-molce-39-1-6]) and FOXO ([@b12-molce-39-1-6]; [@b51-molce-39-1-6]) are important regulators of the cellular redox state ([@b57-molce-39-1-6]; [@b63-molce-39-1-6]), and thus allow for circadian control of antioxidant protein expression. The contribution of p53 and FOXO to redox oscillations have yet to be studied to our knowledge, though we appreciate that their explicit contribution may be masked by direct regulation of the antioxidant response by BMAL:CLOCK. E-BOX mediated circadian regulation of NRF2 expression in the lung is required for rhythmic GSH production ([@b102-molce-39-1-6]), and likely a plethora of other antioxidants ([@b42-molce-39-1-6]). Oscillations in NRF2 expression are also found in several other tissues ([@b106-molce-39-1-6]). In liver, a wide array of genes involved in the antioxidant response exhibit diurnal oscillations. Beyond NRF2 and KEAP1, the expression of NRF2 target genes NQO1, SOD1, CAT and GPX all exhibit circadian expression ([@b150-molce-39-1-6]). NRF2 also regulates the expression of several enzymes involved in NADPH production ([@b82-molce-39-1-6]), allowing BMAL1:CLOCK-NRF2 regulation of NADP/NADPH ratio, and therefore antioxidant recycling. In the brain, NRF2-independent oscillations of ALDH2 and NQO1 are associated with protection from redox-induced neurodegeneration ([@b86-molce-39-1-6]).

The above examples for circadian control of cellular redox state involve transcriptional regulation of either ROS or antioxidant production. Circadian oscillations of PRX oxidation ([@b92-molce-39-1-6]) and GSH:GSSG ratio ([@b111-molce-39-1-6]) however, can occur in the absence of transcriptional cycles, clearly implicating transcription-independent mechanisms in circadian redox control. These remain largely uncharacterised to date, although several biochemical mechanisms have been described that could be relevant. For example, in the adrenal gland, lung, heart and brown adipose tissue, circadian oscillations in oxidation of (mitochondrial) PRX3 are proposed to be regulated through a redox feedback loop involving SRX. Here, mitochondrial ROS induces the oxidation and inactivation of PRX3, allowing H~2~O~2~ to leak into the cytosol. Cytosolic SRX becomes oxidised and forms a complex with HSP90, which allows for the import of SRX into the mitochondria where it reduces PRX3. Because free SRX in the mitochondria is sensitive to LON-mediated degradation, whereas PRX3-bound SRX is protected from this degradation, SRX becomes degraded when its job is done and the cycle begins afresh ([@b59-molce-39-1-6]). The evidence supporting this sequence of molecular events is compelling, however it remains to be seen whether these oscillations are intrinsic to mitochondrial biology, or are driven by rhythmic cues from the surrounding cellular clockwork.

In summary a strong and growing body of evidence suggests that circadian rhythms in redox balance occur cell-autonomously as well as *in vivo*, and moreover that circadian disruption can be associated with deregulation of redox homeostasis.

REDOX CONTROL OF GEFL-MEDIATED TIMEKEEPING
==========================================

As discussed above, redox signals impinge upon many signal transduction pathways. It is therefore plausible that GEFL-mediated timekeeping is also redox-regulated as has been suggested in non-mammalian models. For example, SOD-deficiency in *Neurospora crassa* increases the robustness of overt rhythmicity ([@b153-molce-39-1-6]), and increased ROS concentrations induce shorter circadian period and phase advances. Interestingly, this was very much dependent on the source of ROS, since only metabolically generated ROS had this effect, whereas rhythmic ROS production by NOX did not ([@b44-molce-39-1-6]). Acute manipulation of redox state, e.g. using high extracellular H~2~O~2~, GSH, or diamide, does affect the phase and period in mammalian cells and cultured SCN ([@b135-molce-39-1-6]; [@b140-molce-39-1-6]). Such manipulations certainly suggest that the cellular clock is susceptible exogenous oxidative and reductive stresses, but are not sufficient to demonstrate their relevance in the context of normal cellular timekeeping. Thus we are unaware of any convincing demonstration that oscillations in redox balance normally function to regulate circadian rhythms, although the principle that metabolism regulates the cellular clock is generally accepted ([@b4-molce-39-1-6]). It is the case however, that several possible redox-sensitive clock-relevant regulatory signalling nodes have been identified, as we shall describe.

First, we note that the metabolic oscillations described in the previous section have all been implicated in regulating transcriptional activity of the core clock genes e.g. oscillations in NAD regulate the activity of SIRT1, which in turn regulates PER2 deacetylation and BMAL1:CLOCK activity ([@b5-molce-39-1-6]; [@b89-molce-39-1-6]; [@b114-molce-39-1-6]). The functional evidence that NAD oscillations make a significant contribution to cellular clock function is rather weak however ([@b123-molce-39-1-6]). Thus it remains possible that a certain range of cellular NAD is simply permissive for cellular clock function, and oscillations in steady state NAD levels result simply from a rhythm in consumption.

A second potential route from redox back into the clock is based upon biochemical observations that the affinity of CLOCK:BMAL1 (and NPAS2:BMAL1) heterodimers for DNA E-box elements is regulated by the redox state of NAD(P) cofactors, being favoured by high NAD(P)H, and opposed by high NAD(P) ([@b122-molce-39-1-6]; [@b154-molce-39-1-6]). The biological relevance of these observations are unclear however, since this increased DNA-binding affinity was dependent upon dinucleotide concentrations within the low millimolar range, \>10-fold higher than best estimates for total nuclear NAD(P)H (∼100 μM) ([@b155-molce-39-1-6]). Moreover to elicit circadian regulation of DNA binding would require a substantial oscillation either in ratio of free nuclear NAD(P)H:NAD(P), or else correctly timed, highly localized production of NAD(P)H in the immediate vicinity of the transcriptional complex. At present we are aware of no evidence supporting either scenario.

Rhythms in PRX oxidation suggest that the oxidation status of other proteinthiols might also oscillate and result, for example, in a concomitant release of KEAP1-NRF2 binding, thereby activating downstream NRF2-mediated antioxidant responses. NRF2 transcriptionally activates REV-ERBα expression ([@b151-molce-39-1-6]), though the extent to which this contributes to normal circadian regulation of REV-ERBα is unknown. With respect to direct cysteine-mediated regulation of GEFL clock proteins several possible means of redox input have been described.

A recent x-ray crystal structure identified a tightly bound Zn^2+^ ion at the interface between PER2 and CRY1 ([@b128-molce-39-1-6]). Zn^2+^ co-ordination was shown to be important for stabilising the PER2-CRY1 complex and was further proposed to facilitate the reduction of a nearby intramolecular disulphide bridge in CRY1. Moreover disulphide formation was shown to occur in CRY1 expressed in living cells. Whether or not CRY1 cysteine oxidation oscillates was not reported. A subsequent report by [@b91-molce-39-1-6] confirmed this Zn^2+^-interface, but reported that Cys=\>Ala mutation of the proposed redox-sensitive cysteine had little effect on cellular rhythms. These over-expression studies performed in CRY deficient mouse embryonic fibroblasts do not adequately address the contribution that CRY1 cysteine oxidation may or may not make to the cellular clock, however.

CRY proteins are also regulated by the nutrient-responsive adenosine monophosphate--activated protein kinase (AMPK), with AMPK stimulation leading to CRY phosphorylation and degradation ([@b65-molce-39-1-6]). AMPK is negatively regulated by cysteine oxidation in its α subunit and TRX-mediated AMPK reduction is essential for activation of AMPK during energy starvation ([@b129-molce-39-1-6]). Moreover, CRY1 turnover upon DNA damage is regulated by the deubiquitinase protein USP7/HAUSP ([@b99-molce-39-1-6]), which contains a redox-sensitive cysteine in its active site, that is inhibited by oxidation ([@b70-molce-39-1-6]). Perturbation of either AMPK or USP7 activity affects cellular rhythms, and thus these CRY-regulators introduce, additional plausible means whereby circadian rhythms in redox and metabolism might communicate with the GEFL through its essential CRY repressors. Again however, neither of these possibilities have been explicitly tested.

A further potential redox route into the clockwork lies in a redox-sensitive cysteine within the ligand-binding pocket of another GEFL protein, REV-ERBβ. Both REV-ERBα and β are nuclear receptors for the porphyrin haem, such that haem binding activates repressor activity against target genes ([@b112-molce-39-1-6]). Cysteine oxidation abolishes haem-binding *in vitro*, and has been proposed to act as a "redox switch" in cells. The hypothesis that circadian REV-ERBβ oxidation feeds into the cellular clock has also not been tested however.

It is also perhaps worth mentioning that although cysteine is a relatively rare amino acid residue (∼2% content in mammalian proteins), the strongest point mutant circadian phenotypes *in vivo* and *in vitro*, with regards the speed at which the clock runs, result from missense mutations that involve a cysteine. A Cys =\> Ala mutation in CRY1 ([@b97-molce-39-1-6]), and a Cys =\> Ser mutation in its E3 ligase F-box adaptor (FBXL3) ([@b40-molce-39-1-6]), both result in circadian periods that are 3--4 hours longer than wild type, whereas an Arg =\> Cys mutation in CK1ε results in a clock that runs 3--4 h shorter ([@b73-molce-39-1-6]; [@b81-molce-39-1-6]). Time will tell whether this correlation has any deeper significance.

From these examples it should be clear that whilst several mechanisms have been identified by which cell-autonomous circadian oscillations in redox balance might regulate GEFL activity, a clear demonstration that this actually occurs in mammalian cells is currently lacking.

CONCLUSION
==========

Taken together, there is good evidence for cellular redox state being circadian regulated. Furthermore phenotypes of clock mutants suggest this has clear implications for systemic redox homeostasis. There are several biochemical indications that changes in cellular redox state may function as a circadian input (zeitgeber) and feedback into the cellular clock mechanism. We are not aware, however, of any compelling demonstration that the latter makes a significant contribution in a mammalian cellular context, let alone that it might be a prerequisite for cellular timekeeping. Therefore whilst it is most plausible that redox modulation of the cellular clock takes place, we think it is premature to conclude there is an important role for redox signalling in the mammalian cellular clock.

For redox oscillations to be considered as a mammalian cellular clock mechanism, as has Ca^2+^/cAMP-signalling ([@b93-molce-39-1-6]), it must be shown that: (1) a specific redox couple oscillates in a variety of cellular models; (2) that appropriate manipulation of this redox couple is sufficient to determine the phase, amplitude and period of cellular rhythms; and (3) that specific transduction pathways communicate cyclical redox signals to regulate GEFL function.

To approach the biological significance of redox control of the clock, we also need to understand the molecular underpinnings of PRX-SO~2/3~ oscillations -- what is the timing mechanism that drives them? This question could be answered more readily with robust post-translational reporters for redox balance and ROS levels ([@b33-molce-39-1-6]), rather than indirect markers such as PRX-SO~2/3~. In addition more sophisticated genetic tools are required than gene knockout. For example, SOD1 knockout does not affect timekeeping in mice ([@b49-molce-39-1-6]). Is this because regulated ROS production is not relevant to circadian timekeeping or because compensatory mechanisms (e.g. increased SOD2) are employed? Inducible expression/repression models would be of great utility here.

Furthermore, it has not been strictly established that redox balance needs to oscillate for the cellular clock to function. Might there instead simply be a permissive range where cellular clocks operate? Indeed a similar argument has been made for BMAL1-deficient mice and tissues ([@b85-molce-39-1-6]; [@b86-molce-39-1-6]) i.e. it is plausible that BMAL1 abundance does not need to oscillate as such; rather that sufficient BMAL1 is required to activate antioxidant expression, and without BMAL1 cells succumb to chronic oxidative stress, outside the redox range where the cellular clock can function.

Until these issues have been resolved, we feel it inadvisable to use terms such as "redox oscillator" or "redox clock" since these phrases imply self-sufficiency. Until the underlying mechanism and mode(s) of coupling with GEFLs are firmly established it remains possible that circadian cycles of redox balance are exclusively clock outputs. If metaphors are required, we suggest that the image of a "metabolic cog" normally enmeshed with GEFLs, within the more complex cellular circadian machinery might suffice ([Fig. 4](#f4-molce-39-1-6){ref-type="fig"}). Indeed similarly, we are not aware of any evidence that a minimally reconstituted GEFL would be intrinsically circadian, as has been shown by *in vitro* reconstitution for the entirely post-translational circadian rhythm in the cyanobacteria *Synechococcus elongatus* ([@b90-molce-39-1-6]).

Even without understanding the detailed molecular underpinnings to circadian regulation of the cellular redox state, it is interesting to speculate about the functional consequences that redox oscillations might have upon normal cell signalling ([Fig. 4](#f4-molce-39-1-6){ref-type="fig"}). Just as the clock impacts upon cellular function through regulating the abundance of many key proteins involved in signal transduction and metabolic pathways ([@b78-molce-39-1-6]; [@b119-molce-39-1-6]), so might circadian rhythms in redox balance impact upon redox-sensitive signalling and metabolism. In mice and humans, for example, it has long been believed that synthesis/secretion of corticosteroids in the adrenal cortex are primarily regulated by circadian signaling from the SCN, through the hypothalamus--pituitary--adrenal (HPA) neuroendocrine axis. Recently however, ([@b58-molce-39-1-6]) reported that circadian corticosterone production is accompanied by circadian oscillations in PRX3 and SRX abundance, that were required to protect the cell from increased mitochondrial ROS generation due to steroidogenesis during the latter half of the rest/sleep phase. In steroidogenic tissue-specific SRX-deficient mice, the circadian rhythm of adrenal corticosterone production was suppressed: severely blunting an important systemic cue that normally primes animal physiology for the active/wake phase.

Finally, of course it is quite plausible that circadian rhythms in redox may impact upon the efficacy of redox relay signalling ([@b55-molce-39-1-6]), leading to the possibility that oxidation rhythms exist in other important redox-regulated cytosolic proteins such as GAPDH, KEAP1/NRF2, FOXO, ASK1, PKA, PKG, PTEN, PTP1B etc. If validated this would have far reaching, and potentially translational, consequences for the ways in which we understand the circadian clock machinery to interact with other cellular systems.

In conclusion, there exists great potential for cross fertilisation between research into redox signalling and circadian rhythms. From a basic research perspective it is of prime importance to establish explicitly whether crosstalk occurs bidirectionally and its mechanism(s), but this constitutes no barrier to investigating whether the cell interprets a redox signal differently, depending upon the (biological) time of day.
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![Oxidative cysteine modifications and their recycling. (A) Overview of oxidative cysteine modifications and their respective reduction procces. Abbreviations: Prot X: protein X -- TXN: thioredoxin -- SRX: sulfiredoxin -- GRX: glutaredoxin. (B) Reduction of an inter- or intramolecular disulphide by the thioredoxin system. Thioredoxin reductase (TXNR) is a selenoprotein, containing a selenocysteine (Se) instead of a normal cysteine.](molce-39-1-6f1){#f1-molce-39-1-6}

![Models for how cysteine oxidation occurs *in vivo.* (A) High abundance and reactivity of PRX proteins makes it unlikely that any other cysteine in the cytoplasm could become oxidised. (B) Growth factor signalling induces a localised increase in H~2~O~2~ by inhibiting PRX proteins in at least two manners. The resulting increase in H~2~O~2~ allows the oxidation of less reactive thiols. (C) PRX-mediated redox relay. Oxidised PRX transfers its oxidation to other proteins. Interaction with PRX can mediate the oxidation of specific cysteines upon an increase of the H~2~O~2~ concentration.](molce-39-1-6f2){#f2-molce-39-1-6}

![Models for gene expression feedback loops responsible for circadian gene expression. Simplified representation of the two major gene expression feedback loops. See text for details. CCG, Clock-controlled genes.](molce-39-1-6f3){#f3-molce-39-1-6}

![The role of GEFLs and metabolic oscillations in cellular timekeeping -- multiple cogs in one clock. Cellular timekeeping involves several interconnected molecular systems, which are functionally interdependent under the vast majority of circumstances. At the level of the individual cell, there is no evidence for the existence of multiple clocks. It may instead be appropriate to consider the contribution that different cogs make to a single cellular clock mechanism. Some teeth of each cog make essential contributions to cellular clock function whereas others are auxiliary and/or mediate cell-type specific clock outputs. In addition, some cellular mechanisms, such as ATP generation for example, may simply be permissive for the cellular clock to tick rather than being a state variable of the oscillation. be permissive for the cellular clock to tick rather than being a state variable of the oscillation.](molce-39-1-6f4){#f4-molce-39-1-6}
